Gelonghui, May 10 | According to the latest equity disclosure data of the Stock Exchange, on May 9, 2024, Yuanda Pharmaceutical (00512.HK) was granted an increase of 100,000 shares by Executive Director and Chairman Tang Weikun at an average price of HK$4.887 per share on the market, involving approximately HK$488,700.
After the increase in holdings, Tang Weikun's latest shareholding was 515,000 shares.
